Bellerophon Therapeutics (BLPH): Phase 3 Cleared by FDA – What this means for investors
Bellerophon Therapeutics (BLPH) is a clinical-stage biotherapeutics company. The company is focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Their mission is to